{
  "meta": {
    "title": "05_Anti_Epileptic_Drugs",
    "url": "https://brainandscalpel.vercel.app/05-anti-epileptic-drugs-7747fc41.html",
    "scrapedAt": "2025-11-30T06:59:34.912Z"
  },
  "questions": [
    {
      "id": 74022,
      "choices": [
        {
          "id": 266777,
          "text": "Constipation"
        },
        {
          "id": 266778,
          "text": "Seizures"
        },
        {
          "id": 266779,
          "text": "Dependence"
        },
        {
          "id": 266780,
          "text": "Respiratory depression"
        }
      ],
      "text": "Long term use of pethidine is avoided because a metabolite of pethidine is associated with",
      "unique_key": "Q4621686",
      "question_audio": null,
      "question_video": null,
      "map_id": 34029979,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Seizures Long-term use of pethidine (meperidine) is avoided primarily because of the accumulation of its metabolite, normeperidine, which has neurotoxic effects. Normeperidine is an active metabolite that can accumulate, especially in patients with renal impairment or those receiving prolonged high doses of pethidine. It lowers the seizure threshold and can cause seizures, myoclonus, tremors, and agitation. Unlike other opioids, which primarily cause respiratory depression, pethidine’s neurotoxic effects make it a poor choice for chronic pain management. Explanation of Incorrect Options: Option A (Constipation): While opioid use is commonly associated with constipation due to reduced gastrointestinal motility, this is not the primary reason for avoiding long-term pethidine use. Other opioids like morphine and oxycodone also cause constipation, but they do not have the neurotoxic effects seen with pethidine. Option C (Dependence): Like all opioids, pethidine has the potential for dependence and addiction. However, this is a general concern with opioids rather than a specific reason for avoiding long-term pethidine use. The risk of seizures due to normeperidine accumulation is a more critical issue. Option D (Respiratory depression): Acute opioid toxicity, including pethidine, can cause respiratory depression. However, respiratory depression is not the main concern with chronic pethidine use. The seizure-inducing effects of normeperidine accumulation are the primary reason for avoiding its long-term use.",
      "correct_choice_id": 266778,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7102471700137867/7102471700137867.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7102471700137867/7102471700137867.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74023,
      "choices": [
        {
          "id": 266781,
          "text": "Vitamin E"
        },
        {
          "id": 266782,
          "text": "Vitamin A"
        },
        {
          "id": 266783,
          "text": "Folic acid"
        },
        {
          "id": 266784,
          "text": "Pyridoxine"
        }
      ],
      "text": "Which of the following will you like to give to a pregnant patient to decrease the risk of neural tube defects in the offspring & if your patient is receiving antiepileptic drugs?",
      "unique_key": "Q2506329",
      "question_audio": null,
      "question_video": null,
      "map_id": 34161934,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Folic Acid Folic acid is the most important vitamin for preventing neural tube defects (NTDs) such as spina bifida and anencephaly in the offspring of pregnant women, especially those receiving antiepileptic drugs (AEDs) like valproic acid, carbamazepine, and phenytoin, which can interfere with folate metabolism. Folic acid supplementation (at least 4-5 mg/day) is recommended before conception and during early pregnancy to counteract the folate-depleting effects of AEDs and reduce the risk of congenital malformations. Women on antiepileptic medications are at a higher risk of folate deficiency, making folic acid supplementation even more critical. Explanation of Incorrect Options: Option A: Vitamin E While Vitamin E is an antioxidant and plays a role in fetal development, it does not prevent neural tube defects. Excessive intake of vitamin E in pregnancy has been associated with an increased risk of cardiovascular malformations in the fetus. Option B: Vitamin A Vitamin A (retinol) in high doses is teratogenic and can cause congenital defects such as craniofacial malformations, cardiac anomalies, and central nervous system abnormalities. Although essential for fetal development, it should be taken cautiously in pregnancy, and high doses should be avoided. Option D: Pyridoxine (Vitamin B6) Pyridoxine is beneficial in pregnancy for nausea and vomiting (morning sickness) and is also used to prevent neurotoxicity in patients taking isoniazid. However, it does not reduce the risk of neural tube defects and is not a substitute for folic acid.",
      "correct_choice_id": 266783,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30643821700138728/30643821700138728.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30643821700138728/30643821700138728.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74024,
      "choices": [
        {
          "id": 266785,
          "text": "Clonazepam"
        },
        {
          "id": 266786,
          "text": "Valproic acid"
        },
        {
          "id": 266787,
          "text": "Fosphenytoin"
        },
        {
          "id": 266788,
          "text": "Ethosuximide"
        }
      ],
      "text": "A young male, Farhan suffers from a seizure disorder which is characterized by tonic rigidity of limbs followed in 20-30 sec by tremors progressing to massive jerking of the body. This clonic phase lasts for 1-3 min. The anti-seizure drug of choice for this patient is",
      "unique_key": "Q8175368",
      "question_audio": null,
      "question_video": null,
      "map_id": 34807921,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Valproic Acid The description of the seizure—tonic rigidity of limbs followed by tremors and massive jerking movements—is characteristic of a generalized tonic-clonic seizure (GTCS), also known as a grand mal seizure. Valproic acid is the drug of choice for generalized tonic-clonic seizures due to its broad-spectrum activity. It works by increasing GABA levels and blocking voltage-gated sodium channels, stabilizing neuronal excitability. It is also effective against other generalized seizures, including absence and myoclonic seizures, making it a versatile antiepileptic drug. It has a good safety profile and is well-tolerated in most patients. Explanation of Incorrect Options: Option A: Clonazepam Clonazepam is a benzodiazepine, mainly used for absence seizures, myoclonic seizures, and anxiety disorders. It has sedative properties and is not the first-line treatment for generalized tonic-clonic seizures. Additionally, long-term use leads to tolerance and dependence. Option C: Fosphenytoin Fosphenytoin is a prodrug of phenytoin, which is primarily used for status epilepticus and seizure prevention. While phenytoin is effective for generalized tonic-clonic seizures, valproic acid is preferred due to its broader spectrum and better tolerability. Phenytoin has narrow therapeutic index, leading to potential toxicity and side effects such as gingival hyperplasia, ataxia, and arrhythmias. Option D: Ethosuximide Ethosuximide is only effective for absence seizures and has no role in generalized tonic-clonic seizures. It works by blocking T-type calcium channels, which are involved in absence seizure pathophysiology.",
      "correct_choice_id": 266786,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/4223781700138762/4223781700138762.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/4223781700138762/4223781700138762.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74025,
      "choices": [
        {
          "id": 266789,
          "text": "Intramuscular phenobarbitone"
        },
        {
          "id": 266790,
          "text": "Intravenous phenytoin sodium"
        },
        {
          "id": 266791,
          "text": "Intravenous diazepam"
        },
        {
          "id": 266792,
          "text": "Rectal diazepam"
        }
      ],
      "text": "Status epilepticus is managed best with the use of which of the following drugs?",
      "unique_key": "Q8953702",
      "question_audio": null,
      "question_video": null,
      "map_id": 34927472,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Intravenous diazepam Status epilepticus (SE) is a medical emergency characterized by continuous seizures lasting >5 minutes or recurrent seizures without recovery of consciousness. The first-line treatment for SE is intravenous (IV) benzodiazepines, with IV diazepam being one of the most effective options. Diazepam is a benzodiazepine that enhances GABAergic inhibition by increasing the frequency of chloride channel opening via GABA-A receptor activation. It rapidly terminates seizures within minutes, making it ideal for emergency use. However, it has a short duration of action, often requiring a longer-acting agent (such as IV phenytoin or fosphenytoin) to maintain seizure control. Incorrect Options: Option A: Intramuscular phenobarbitone Phenobarbitone (phenobarbital) is not the first-line drug for status epilepticus. Although it is a potent GABA-A agonist, its onset of action is slow compared to benzodiazepines. IM administration is less effective and slower than IV diazepam in stopping active seizures. Phenobarbitone is usually reserved for refractory status epilepticus. Option B: Intravenous phenytoin sodium IV phenytoin is used as a second-line agent to prevent seizure recurrence after the initial seizure is controlled. However, it does not work quickly enough to terminate an active seizure. Additionally, IV phenytoin can cause serious cardiovascular side effects (hypotension, arrhythmias) and requires slow infusion. Option D: Rectal diazepam Rectal diazepam can be used if IV access is not available (e.g., in children or pre-hospital settings). However, IV diazepam is preferred in a hospital setting due to faster and more predictable absorption. Rectal administration is less effective in severe status epilepticus.",
      "correct_choice_id": 266791,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40383311700138791/40383311700138791.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40383311700138791/40383311700138791.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74026,
      "choices": [
        {
          "id": 266793,
          "text": "Rectal diazepam"
        },
        {
          "id": 266794,
          "text": "Intravenous phenytoin"
        },
        {
          "id": 266795,
          "text": "Intramuscular phenobarbitone"
        },
        {
          "id": 266796,
          "text": "Oral sodium valproate"
        }
      ],
      "text": "A patient, Rama was diagnosed to be having febrile commissions in the pediatric emergency. which of the following can be used for the treatment of this patient?",
      "unique_key": "Q2845017",
      "question_audio": null,
      "question_video": null,
      "map_id": 34324565,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Rectal diazepam Febrile seizures (febrile convulsions) are seizures triggered by fever in children, usually between 6 months and 5 years of age, without an underlying neurological disorder. Most febrile seizures are self-limiting, but prolonged or recurrent seizures require treatment. Rectal diazepam is the preferred treatment for acute febrile seizures in pediatric emergencies when IV access is not readily available. Diazepam is a benzodiazepine that enhances GABAergic inhibition, rapidly stopping seizures. Rectal administration is effective, fast-acting, and safe, especially in young children who may not have IV access. For prolonged seizures, IV benzodiazepines (such as IV lorazepam or IV diazepam) are preferred if available. Explanation of Incorrect Options: Option B: Intravenous phenytoin IV phenytoin is not first-line for febrile seizures as it does not act rapidly enough to stop an ongoing seizure. It is typically used in status epilepticus or for preventing seizure recurrence rather than for acute management. Phenytoin can also cause cardiac side effects (hypotension, arrhythmias) and requires slow IV infusion. Option C: Intramuscular phenobarbitone Phenobarbitone (phenobarbital) is not preferred for febrile seizures due to its slow onset of action. While it is effective in seizure control, it has sedative and cognitive side effects, making it less desirable in children. IM administration is painful and not as rapid as rectal diazepam. Option D: Oral sodium valproate Valproate is used for long-term seizure control, not acute management of febrile seizures. It has a delayed onset of action and does not work quickly enough to stop a febrile seizure. Additionally, valproate is not typically recommended in children under 2 years due to the risk of hepatotoxicity.",
      "correct_choice_id": 266793,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/3795841700138835/3795841700138835.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/3795841700138835/3795841700138835.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74027,
      "choices": [
        {
          "id": 266797,
          "text": "Anorexia"
        },
        {
          "id": 266798,
          "text": "Loss bf hair"
        },
        {
          "id": 266799,
          "text": "Hepatitis"
        },
        {
          "id": 266800,
          "text": "Tremor"
        }
      ],
      "text": "The most common adverse effect particularly seen in young children because of the use of sodium valproate is",
      "unique_key": "Q4506039",
      "question_audio": null,
      "question_video": null,
      "map_id": 34337189,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hepatitis Sodium valproate is a broad-spectrum antiepileptic drug (AED) used for generalized and focal seizures, bipolar disorder, and migraine prophylaxis. However, its use in young children (<2 years old) carries a significant risk of hepatotoxicity. Valproate-induced hepatitis (hepatic failure) is the most serious adverse effect, particularly in children under 2 years due to their immature liver metabolism. This occurs due to mitochondrial toxicity, leading to hepatic dysfunction, jaundice, vomiting, lethargy, and coagulopathy. The risk is higher in those with metabolic disorders (e.g., urea cycle defects, mitochondrial diseases). Regular liver function tests (LFTs) are essential, especially in the first 6 months of therapy. Explanation of Incorrect Options: Option A: Anorexia Anorexia and nausea can occur with valproate use, especially at the start of treatment. However, this is usually mild and transient and not the most serious adverse effect. Weight gain is actually more common with long-term valproate use. Option B: Loss of hair (Alopecia) Valproate can cause reversible hair loss, with hair regrowing as curly or thinner. This occurs in 5–10% of patients, but it is not the most common or serious side effect in young children. Option D: Tremor Tremor is a dose-related side effect of valproate, more commonly seen in adults. It is not as common in children and is usually mild, affecting fine motor control. Hepatitis, in contrast, is potentially life-threatening and requires early detection.",
      "correct_choice_id": 266799,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66067251700139359/66067251700139359.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66067251700139359/66067251700139359.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74028,
      "choices": [
        {
          "id": 266801,
          "text": "Lamotrigine"
        },
        {
          "id": 266802,
          "text": "Primidone"
        },
        {
          "id": 266803,
          "text": "Sodium valproate"
        },
        {
          "id": 266804,
          "text": "Ethosuximide"
        }
      ],
      "text": "The drug used in absence seizures and having a narrow spectrum of antiepileptic activity is",
      "unique_key": "Q9278653",
      "question_audio": null,
      "question_video": null,
      "map_id": 34562861,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Ethosuximide Ethosuximide is the drug of choice for absence seizures, a type of generalized epilepsy characterized by brief lapses in consciousness with 3-Hz spike-and-wave discharges on EEG. It has a narrow spectrum of activity, meaning it is effective only against absence seizures and not other types of seizures like tonic-clonic or focal seizures. Mechanism of Action: It works by inhibiting T-type calcium channels in thalamic neurons, which play a crucial role in the pathogenesis of absence seizures. Preferred in children due to its effectiveness and relatively mild side effect profile, though it can cause GI distress, fatigue, and rare blood dyscrasias. Explanation of Incorrect Options: Option A: Lamotrigine Lamotrigine is a broad-spectrum AED that is effective for absence seizures, focal seizures, and generalized tonic-clonic seizures. It is also used in bipolar disorder but is not the most specific drug for absence seizures. Additionally, it carries the risk of Stevens-Johnson syndrome, particularly when titrated too quickly. Option B: Primidone Primidone is metabolized to phenobarbital, a barbiturate, and is mainly used for focal and generalized tonic-clonic seizures. It has no significant effect on absence seizures and is not a first-line option for epilepsy today. It is more commonly used for essential tremor. Option C: Sodium Valproate Valproate is a broad-spectrum AED, effective in absence, tonic-clonic, and myoclonic seizures. While it is effective for absence seizures, it is not the most specific drug for this condition. It also has higher toxicity in children, including hepatotoxicity, pancreatitis, and teratogenic effects.",
      "correct_choice_id": 266804,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68835511700139798/68835511700139798.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68835511700139798/68835511700139798.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74029,
      "choices": [
        {
          "id": 266805,
          "text": "Gum hyperplasia"
        },
        {
          "id": 266806,
          "text": "Hirsutism"
        },
        {
          "id": 266807,
          "text": "Ataxia"
        },
        {
          "id": 266808,
          "text": "All of the above"
        }
      ],
      "text": "High plasma drug concentration of phenytoin can cause which of the following adverse effects?",
      "unique_key": "Q3037214",
      "question_audio": null,
      "question_video": null,
      "map_id": 34727072,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Ataxia Ataxia is a dose-dependent adverse effect of phenytoin and occurs at high plasma concentrations due to cerebellar toxicity. Phenytoin follows zero-order kinetics at higher doses, meaning small dose increases can lead to disproportionate rises in plasma levels, increasing the risk of toxicity. Ataxia manifests as an unsteady gait, impaired coordination, slurred speech, and difficulty with fine motor movements. Other neurologic toxicities at high concentrations include nystagmus, dizziness, diplopia, and confusion. Explanation of Incorrect Options: Option A: Gum Hyperplasia Gingival hyperplasia is a chronic adverse effect of phenytoin, not directly related to high plasma levels. It occurs due to increased fibroblast proliferation and can be minimized with good oral hygiene. It is a common side effect, particularly in children and adolescents on long-term therapy. Option B: Hirsutism Hirsutism (excessive hair growth) is another long-term side effect of phenytoin, not directly related to high plasma drug levels. It results from phenytoin-induced androgen-like effects and is more common in females. Option D: All of the Above This option is incorrect because only ataxia occurs due to high plasma concentrations, whereas gum hyperplasia and hirsutism are long-term effects that do not depend on plasma drug levels.",
      "correct_choice_id": 266807,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21580211700139810/21580211700139810.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21580211700139810/21580211700139810.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74030,
      "choices": [
        {
          "id": 266809,
          "text": "Capacity limited metabolism saturating at higher therapeutic concentration range"
        },
        {
          "id": 266810,
          "text": "Nonsaturation kinetics of metabolism"
        },
        {
          "id": 266811,
          "text": "High first pass metabolism"
        },
        {
          "id": 266812,
          "text": "Extrahepatic metabolism"
        }
      ],
      "text": "Phenytoin pharmacokinetics is highlighted by which of the following characteristics?",
      "unique_key": "Q6092736",
      "question_audio": null,
      "question_video": null,
      "map_id": 34903062,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Capacity-limited metabolism saturating at higher therapeutic concentration range Phenytoin follows capacity-limited (Michaelis-Menten) metabolism, meaning that its elimination is saturable at higher doses. At low plasma concentrations, phenytoin is metabolized by the liver through first-order kinetics (i.e., a constant fraction is eliminated per unit time). As the plasma concentration increases and approaches the enzyme saturation point, the metabolism shifts to zero-order kinetics, where a fixed amount of drug is eliminated per unit time, regardless of concentration. This leads to a nonlinear increase in plasma drug levels with small dose increments, making phenytoin dosing highly unpredictable and requiring careful monitoring. This capacity-limited metabolism is clinically significant because even small dose adjustments can lead to toxicity due to excessive plasma accumulation. Explanation of Incorrect Options: Option B: Non-saturation kinetics of metabolism Incorrect because phenytoin metabolism is saturable at higher doses. If metabolism were non-saturable, it would follow first-order kinetics throughout, which is not true for phenytoin. Option C: High first-pass metabolism Phenytoin undergoes hepatic metabolism, but it has a high oral bioavailability (70-90%), meaning it does not undergo significant first-pass metabolism. High first-pass metabolism is seen with drugs like propranolol and nitroglycerin. Option D: Extrahepatic metabolism Incorrect because phenytoin is primarily metabolized in the liver by CYP2C9 and CYP2C19 enzymes. It has minimal extrahepatic metabolism.",
      "correct_choice_id": 266809,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64618071700139822/64618071700139822.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64618071700139822/64618071700139822.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74031,
      "choices": [
        {
          "id": 266813,
          "text": "Blocks neuronal reuptake of GABA"
        },
        {
          "id": 266814,
          "text": "Drug of choice in absence seizures"
        },
        {
          "id": 266815,
          "text": "Visual disturbances can occur"
        },
        {
          "id": 266816,
          "text": "Lift threatening skin disorders may occur"
        }
      ],
      "text": "Which of the following statements about vigabatrin is TRUE?",
      "unique_key": "Q1945650",
      "question_audio": null,
      "question_video": null,
      "map_id": 34994637,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Visual disturbances can occur Vigabatrin is an irreversible inhibitor of GABA transaminase, leading to increased levels of GABA in the brain, which has an anticonvulsant effect. A major adverse effect of vigabatrin is visual disturbances, specifically progressive, irreversible concentric visual field constriction (tunnel vision). This occurs due to retinal toxicity, and patients on vigabatrin require regular ophthalmologic monitoring. Due to this serious adverse effect, vigabatrin is reserved for refractory epilepsy and infantile spasms (West syndrome) when other treatments fail. Explanation of Incorrect Options: Option A: Blocks neuronal reuptake of GABA Incorrect because vigabatrin does not block GABA reuptake. Instead, it inhibits GABA transaminase, preventing GABA breakdown and leading to increased synaptic GABA levels. Tiagabine, not vigabatrin, blocks GABA reuptake. Option B: Drug of choice in absence seizures Incorrect because vigabatrin is not used for absence seizures. Ethosuximide and valproic acid are the preferred drugs for absence seizures. Vigabatrin is mainly used for infantile spasms (West syndrome) and refractory focal seizures. Option D: Life-threatening skin disorders may occur Incorrect because vigabatrin is not associated with severe skin reactions. Lamotrigine is the antiepileptic drug most commonly linked to life-threatening skin disorders like Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN).",
      "correct_choice_id": 266815,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61863981700139836/61863981700139836.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61863981700139836/61863981700139836.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74032,
      "choices": [
        {
          "id": 266817,
          "text": "Buspirone"
        },
        {
          "id": 266818,
          "text": "Zaleplon"
        },
        {
          "id": 266819,
          "text": "Phenobarbital"
        },
        {
          "id": 266820,
          "text": "Diazepam"
        }
      ],
      "text": "Which of the following hypnotic drugs facilitates the inhibitory actions of GABA but lacks anticonvulsant or muscle relaxing properties and has minimal effect on sleep architecture?",
      "unique_key": "Q8974325",
      "question_audio": null,
      "question_video": null,
      "map_id": 34675815,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Zaleplon Zaleplon is a non-benzodiazepine hypnotic that selectively acts on the benzodiazepine-1 (BZ1) subtype of the GABA-A receptor, facilitating inhibitory actions of GABA. Unlike benzodiazepines and barbiturates, it lacks anticonvulsant and muscle relaxant properties. A key advantage of zaleplon is that it has minimal effects on sleep architecture, meaning it does not significantly alter sleep stages such as REM or deep sleep. It is primarily used for short-term treatment of insomnia, particularly for sleep-onset difficulties due to its rapid onset and short half-life. Incorrect Options: (A) Buspirone – Incorrect Buspirone is an anxiolytic that primarily acts as a partial agonist at serotonin (5-HT1A) receptors. It does not interact with GABA receptors and lacks hypnotic, anticonvulsant, and muscle relaxant properties. It is mainly used for generalized anxiety disorder (GAD) rather than for sleep induction. (C) Phenobarbital – Incorrect Phenobarbital is a barbiturate that enhances GABAergic activity but has strong anticonvulsant and sedative properties. It also significantly affects sleep architecture by suppressing REM sleep, making it unsuitable as a preferred hypnotic for sleep maintenance. (D) Diazepam – Incorrect Diazepam is a benzodiazepine that facilitates GABA-A receptor activity, but unlike zaleplon, it has strong anticonvulsant, anxiolytic, and muscle relaxant effects. It also disrupts sleep architecture by reducing deep sleep (slow-wave sleep) and REM sleep, making it less desirable for treating insomnia compared to non-benzodiazepine hypnotics like zaleplon.",
      "correct_choice_id": 266818,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40177011700140258/40177011700140258.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40177011700140258/40177011700140258.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74033,
      "choices": [
        {
          "id": 266821,
          "text": "Aspartate"
        },
        {
          "id": 266822,
          "text": "Glutamate"
        },
        {
          "id": 266823,
          "text": "GABA"
        },
        {
          "id": 266824,
          "text": "Glycine"
        }
      ],
      "text": "In strychnine poisoning, convulsions occur because of the antagonist effects at receptors for.",
      "unique_key": "Q3038024",
      "question_audio": null,
      "question_video": null,
      "map_id": 34124258,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Glycine Strychnine poisoning leads to convulsions due to its antagonistic action at glycine receptors in the spinal cord and brainstem. Glycine is an inhibitory neurotransmitter that primarily acts in the spinal cord to suppress excessive neuronal excitability. By blocking glycine receptors, strychnine removes inhibitory control, leading to hyperexcitation of motor neurons and severe, uncontrolled convulsions. These convulsions are exacerbated by even minor stimuli like touch or noise and can lead to respiratory failure due to diaphragm paralysis. Incorrect Options: (A) Aspartate – Incorrect Aspartate is an excitatory neurotransmitter in the CNS, similar to glutamate. However, strychnine poisoning is not related to aspartate's activity, as the convulsions result from loss of inhibitory control rather than increased excitatory signaling. (B) Glutamate – Incorrect Glutamate is the primary excitatory neurotransmitter in the brain, acting through NMDA, AMPA, and kainate receptors. While excessive glutamate activity can lead to excitotoxicity and seizures, strychnine does not directly affect glutamate receptors. Instead, the loss of glycine's inhibition indirectly increases neuronal excitability, leading to convulsions. (C) GABA – Incorrect GABA (gamma-aminobutyric acid) is the major inhibitory neurotransmitter in the brain, acting via GABA-A and GABA-B receptors. While GABA inhibition can also cause seizures, strychnine specifically targets glycine receptors, not GABAergic pathways. Drugs like picrotoxin and bicuculline, which block GABA receptors, cause seizures differently from strychnine.",
      "correct_choice_id": 266824,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62839171700140298/62839171700140298.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62839171700140298/62839171700140298.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74034,
      "choices": [
        {
          "id": 266825,
          "text": "Caused by blockade of dopamine receptors"
        },
        {
          "id": 266826,
          "text": "Less likely to be produced by clozapine than by chlorpromazine"
        },
        {
          "id": 266827,
          "text": "Can be counteract to some degree by ant muscarinic drugs"
        },
        {
          "id": 266828,
          "text": "Haloperidol does not cause extrapyramidal syndrome"
        }
      ],
      "text": "Which of following statements about extrapyramidal effects of antipsychotic drugs is FALSE?",
      "unique_key": "Q7892328",
      "question_audio": null,
      "question_video": null,
      "map_id": 34743308,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Haloperidol does not cause extrapyramidal syndrome – FALSE Haloperidol is a high-potency typical antipsychotic that strongly blocks dopamine D2 receptors in the nigrostriatal pathway. This blockade disrupts normal dopamine-acetylcholine balance in the basal ganglia, leading to extrapyramidal side effects (EPS) such as acute dystonia, parkinsonism, akathisia, and tardive dyskinesia. Haloperidol is one of the most common antipsychotics associated with EPS, making this statement false. Incorrect Options: (A) Caused by blockade of dopamine receptors – TRUE EPS occur due to dopamine D2 receptor blockade in the nigrostriatal pathway. Since dopamine normally inhibits excessive acetylcholine activity in the basal ganglia, its blockade leads to relative overactivity of cholinergic neurons, causing movement disorders. (B) Less likely to be produced by clozapine than by chlorpromazine – TRUE Clozapine is an atypical antipsychotic with low D2 receptor affinity and a stronger effect on serotonin (5-HT2A) receptors, reducing the risk of EPS. In contrast, chlorpromazine, a low-potency typical antipsychotic, has higher D2 antagonism in the nigrostriatal pathway, leading to a higher risk of EPS. (C) Can be counteracted to some degree by antimuscarinic drugs – TRUE Antimuscarinic drugs (e.g., benztropine, trihexyphenidyl) help restore the dopamine-acetylcholine balance in the basal ganglia by blocking excess cholinergic activity, reducing EPS symptoms such as parkinsonism and dystonia.",
      "correct_choice_id": 266828,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22892511700140422/22892511700140422.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22892511700140422/22892511700140422.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74035,
      "choices": [
        {
          "id": 266829,
          "text": "Stop sodium valproate and start lamotrigine as it is more safe in pregnancy"
        },
        {
          "id": 266830,
          "text": "Stop all medicaltions at all"
        },
        {
          "id": 266831,
          "text": "Add lamotrigine to sodium valproate for better control of seizure as pregnancy lead to more incidence of seizures"
        },
        {
          "id": 266832,
          "text": "Continue with sodium valproate and add folic acid to prevent neural tube defects"
        }
      ],
      "text": "A 28 yr old female, known case of myoclonic epilepsy, taking sodium valproate since 2years and her epilepsy is well controlled. Now patient has become pregnant and comes to you for advise as she has come to know that valproate is a strongly associated with teratogenesis. What will be best advice for her antiepileptic treatment?",
      "unique_key": "Q7560529",
      "question_audio": null,
      "question_video": null,
      "map_id": 34370266,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Continue with sodium valproate and add folic acid to prevent neural tube defects. Valproate is indeed associated with teratogenesis, specifically with an increased risk of neural tube defects (such as spina bifida) and other congenital malformations. However, in cases where epilepsy is well-controlled with valproate, abruptly discontinuing the medication can increase the risk of seizures, which can be more harmful both to the mother and the fetus. The best approach in this scenario is to continue the sodium valproate but add folic acid supplementation, as folic acid has been shown to reduce the risk of neural tube defects, even when the mother is on an antiepileptic drug like valproate. This ensures that the patient maintains seizure control while also taking steps to mitigate the risk of fetal malformations. Explanation of Incorrect Options: (A) Stop sodium valproate and start lamotrigine as it is more safe in pregnancy – Incorrect. While lamotrigine is considered safer than valproate during pregnancy, it is not entirely without risk. Switching medications may not be appropriate in a patient whose epilepsy is well-controlled with sodium valproate, as seizure control is critical during pregnancy to prevent maternal and fetal complications. Additionally, lamotrigine can still carry risks, including potential effects on the fetus, and its dosing may need to be adjusted during pregnancy due to altered pharmacokinetics. Therefore, stopping valproate without ensuring alternative seizure control is not the optimal approach. (B) Stop all medications at all – Incorrect. Discontinuing all antiepileptic medications is highly inappropriate, as this would put the patient at risk for seizures, which can lead to serious complications for both the mother and the fetus, including pregnancy loss, fetal injury, and preterm birth. Seizure control is essential during pregnancy, and discontinuing medications without appropriate alternative management would significantly jeopardize the patient's health and well-being. (C) Add lamotrigine to sodium valproate for better control of seizure as pregnancy leads to more incidence of seizures – Incorrect. While it is true that pregnancy can alter seizure thresholds and increase the risk of seizures, adding lamotrigine to sodium valproate may not always be necessary, especially if the patient's seizures are well-controlled on valproate alone. Polytherapy can increase the risk of drug interactions and side effects, and careful consideration is needed before introducing a second antiepileptic drug. Moreover, the primary focus in pregnancy should be to maintain seizure control while minimizing risks to the fetus, so switching to or adding a new drug should be done only when clearly needed.",
      "correct_choice_id": 266832,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58224611700304843/58224611700304843.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58224611700304843/58224611700304843.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74036,
      "choices": [
        {
          "id": 266833,
          "text": "Sodium valproate"
        },
        {
          "id": 266834,
          "text": "Rufinamide"
        },
        {
          "id": 266835,
          "text": "Topiramate"
        },
        {
          "id": 266836,
          "text": "Carbamzepine"
        }
      ],
      "text": "A child has come to you with multiple different types of seizures, particularly tonic and atonic seizures. Intellectual development of this child is impaired. The EEG shows a classic pattern of background slowing and spike-wave bursts at frequencies less than 2.5 per second. Which drug shouldn’t be a part of the treatment for the above disease?",
      "unique_key": "Q6028011",
      "question_audio": null,
      "question_video": null,
      "map_id": 34390863,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Carbamazepine. The child described in the question most likely has Lennox-Gastaut syndrome (LGS), which is characterized by multiple types of seizures, impaired intellectual development, and a specific EEG pattern showing background slowing and spike-wave bursts at frequencies less than 2.5 Hz. Lennox-Gastaut syndrome is a severe form of epilepsy, often with drug resistance to treatment. Carbamazepine is not recommended for use in Lennox-Gastaut syndrome because it can worsen the seizures. In fact, carbamazepine can induce seizures in patients with this syndrome, particularly atonic seizures. This is because carbamazepine is a proconvulsant in certain types of epilepsy, including Lennox-Gastaut syndrome, and can exacerbate the frequency and severity of the seizures in these patients. Explanation of Incorrect Options: (A) Sodium valproate – Incorrect. Sodium valproate is one of the first-line treatments for Lennox-Gastaut syndrome and is effective in controlling a variety of seizure types, including tonic and atonic seizures. It is considered one of the most commonly used anticonvulsants in the management of epileptic encephalopathies, including Lennox-Gastaut syndrome. It works by enhancing GABAergic activity and inhibiting voltage-gated sodium channels, making it effective for controlling seizures in LGS. (B) Rufinamide – Incorrect. Rufinamide is another medication that is commonly used in the treatment of Lennox-Gastaut syndrome. It is specifically approved for the treatment of seizures associated with LGS and is effective in reducing the frequency of tonic and atonic seizures. Rufinamide works by modulating sodium channels, which helps stabilize neuronal membranes and prevent excessive neuronal firing, making it a useful agent for managing this syndrome. (C) Topiramate – Incorrect. Topiramate is also used in the treatment of Lennox-Gastaut syndrome and is effective in controlling multiple seizure types, including tonic and atonic seizures. It works through several mechanisms, including blocking voltage-gated sodium channels, enhancing GABAergic activity, and inhibiting glutamate receptors. While not typically first-line therapy, topiramate is a useful option for treating seizures in patients with Lennox-Gastaut syndrome.",
      "correct_choice_id": 266836,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17729631700304923/17729631700304923.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17729631700304923/17729631700304923.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74037,
      "choices": [
        {
          "id": 266837,
          "text": "Continue the same medicine as recurrence rate is high while changing the treatment"
        },
        {
          "id": 266838,
          "text": "Stop sodium valproate and switch to levitiracetam as it is safe"
        },
        {
          "id": 266839,
          "text": "Stop sodium valproate gradually and wait for few more months and conceive without taking anti epileptic drug if seizure wont recur"
        },
        {
          "id": 266840,
          "text": "Its better to postpone the plan to conceive as all anti epileptics have some risk of teratogenesis"
        }
      ],
      "text": "A 26 year old non pregnant female known case of primary generalized tonic-clonic seizures since 5 years, well controlled on sodium valproate , wants to conceive and comes to you to take advice for her anti epileptic treatment. Which of the following best advise to her ?",
      "unique_key": "Q7543994",
      "question_audio": null,
      "question_video": null,
      "map_id": 34026673,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Stop sodium valproate gradually and wait for a few more months and conceive without taking an antiepileptic drug if seizures don’t recur. Explanation for the Correct Answer: Sodium valproate is a highly teratogenic antiepileptic drug (AED), associated with: Neural tube defects (e.g., spina bifida, anencephaly) Facial dysmorphism, congenital heart defects, and limb abnormalities Neurodevelopmental delay and autism spectrum disorders Given that this patient has been seizure-free for years, stopping valproate gradually and monitoring for seizure recurrence before conception is the safest approach. If seizures do not recur after discontinuation, pregnancy can be planned without requiring an AED. This approach minimizes the teratogenic risk while also avoiding unnecessary medication if epilepsy is in remission. Explanation for the Incorrect Answers: A) Continue the same medicine as recurrence rate is high while changing the treatment While seizure recurrence is a concern, sodium valproate poses an unacceptably high teratogenic risk. Alternative AEDs with lower risk should be considered, or discontinuation should be attempted. B) Stop sodium valproate and switch to levetiracetam as it is safe Levetiracetam is a safer alternative for pregnancy but should not be started abruptly. If seizure-free for years, it is better to attempt discontinuation first rather than switching immediately. If seizures recur, levetiracetam or lamotrigine can be used as they have a better safety profile in pregnancy. D) It’s better to postpone the plan to conceive as all anti-epileptics have some risk of teratogenesis While AEDs have some teratogenic risk, certain drugs like levetiracetam and lamotrigine are relatively safe. Postponing pregnancy is not necessary if seizures remain under control without medication.",
      "correct_choice_id": 266839,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55967581700305622/55967581700305622.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55967581700305622/55967581700305622.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74038,
      "choices": [
        {
          "id": 266841,
          "text": "Thrombocytopenia"
        },
        {
          "id": 266842,
          "text": "Hepatotoxicity"
        },
        {
          "id": 266843,
          "text": "Agranulocytosis"
        },
        {
          "id": 266844,
          "text": "Pancreatitits"
        }
      ],
      "text": "A 35 year male patient taking sodium valproate for his epileptic disease, now comes to you with severe grade of trigeminal neuralgia and you have decided to add carbamazepine to his treatment schedule. Which of the following side effect incidence can be enhanced due to above drug combination?",
      "unique_key": "Q4240216",
      "question_audio": null,
      "question_video": null,
      "map_id": 34247358,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Hepatotoxicity. Explanation for the Correct Answer: Both sodium valproate and carbamazepine are known to have hepatotoxic potential, and their combination increases the risk of liver damage due to synergistic hepatotoxicity. Sodium valproate can cause dose-dependent hepatotoxicity, particularly in children under 2 years, but also in adults. It leads to mitochondrial dysfunction and fatty liver degeneration. Carbamazepine is associated with idiosyncratic hepatotoxicity, which can manifest as cholestatic or mixed liver injury. When used together, these drugs can increase liver enzyme levels, leading to acute hepatic failure in rare cases. Monitoring liver function tests (LFTs) regularly is crucial when combining these drugs. Explanation for the Incorrect Answers: A) Thrombocytopenia Sodium valproate is known to cause thrombocytopenia by suppressing bone marrow platelet production. However, carbamazepine does not enhance this effect; instead, it is more commonly associated with leukopenia or agranulocytosis. The combination does not significantly increase thrombocytopenia risk compared to valproate alone. C) Agranulocytosis Carbamazepine is known to cause agranulocytosis, but sodium valproate does not significantly contribute to this effect. The risk of bone marrow suppression is greater with carbamazepine alone rather than in combination with valproate. D) Pancreatitis Sodium valproate can cause pancreatitis, but this is a rare and idiosyncratic reaction. Carbamazepine is not associated with pancreatitis, so their combination does not increase pancreatitis risk.",
      "correct_choice_id": 266842,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55792121700305635/55792121700305635.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55792121700305635/55792121700305635.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74039,
      "choices": [
        {
          "id": 266845,
          "text": "Sodium valproate"
        },
        {
          "id": 266846,
          "text": "Levetiracetam"
        },
        {
          "id": 266847,
          "text": "Lamotrigine"
        },
        {
          "id": 266848,
          "text": "Esketamine"
        }
      ],
      "text": "A 65 years old male, K/C/O DM-II and CVA and on multiple medicines for same problems, comes to hospital OPD with history of generalised seizure one night before. His renal function was normal. Which of the following should be the best choice to start treatment for this patient?",
      "unique_key": "Q6482493",
      "question_audio": null,
      "question_video": null,
      "map_id": 34319041,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Levetiracetam. Explanation for the Correct Answer: Levetiracetam is the best choice for treating new-onset generalized seizures in an elderly patient with multiple comorbidities (diabetes and cerebrovascular accident - CVA) because: Favorable safety profile: Levetiracetam is well tolerated in elderly patients and has minimal drug interactions, which is important since this patient is on multiple medications. No significant hepatic metabolism: It is primarily excreted unchanged in urine, making it safer for patients with multiple medications that may affect liver enzymes. Lower risk of cognitive and behavioral side effects: Compared to other antiepileptics, levetiracetam has a lower risk of sedation, dizziness, and cognitive impairment, which are concerns in elderly patients. Effective in generalized and focal seizures: It is broad-spectrum, meaning it is effective for both generalized and focal seizures, including post-stroke seizures. Explanation for the Incorrect Answers: A) Sodium valproate Not preferred in elderly due to higher risk of side effects, including hepatotoxicity, weight gain, and tremors. Drug interactions: Valproate inhibits cytochrome P450, potentially interfering with other medications used for diabetes and stroke prevention (e.g., anticoagulants, antihypertensives). Risk of thrombocytopenia: Older adults are more prone to valproate-induced thrombocytopenia, increasing the risk of bleeding. C) Lamotrigine Good alternative, but slower titration is required due to the risk of Stevens-Johnson syndrome (SJS). Not ideal for immediate seizure control as it takes weeks to reach an effective dose. Drug interactions: Metabolism is affected by enzyme-inducing or inhibiting drugs, which can be problematic in a patient on multiple medications. D) Esketamine Not an antiepileptic drug (AED); it is used for treatment-resistant depression. No role in seizure management and could even lower seizure threshold in some cases.",
      "correct_choice_id": 266846,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46925971700305648/46925971700305648.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46925971700305648/46925971700305648.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74040,
      "choices": [
        {
          "id": 266849,
          "text": "Patient should not take drug dose more than 400 mg/day"
        },
        {
          "id": 266850,
          "text": "He should not frequently switch to other generic phenytoin preparation available in market to make treatment more economical"
        },
        {
          "id": 266851,
          "text": "He should continue rest of drugs as a part of his DVT treatment"
        },
        {
          "id": 266852,
          "text": "Cholecalciferol supplementation to be taken on & off during treatment"
        }
      ],
      "text": "A patient who is daily wage labour by profession and a known case of epilepsy with DVT since last 10 years, was maintained on tablet phenytoin 300 mg HS, tab warfarin 5mg OD and tab aspirin 75 mg OD. He has now come to you with recurrent episode of seizure. He also gives history of sudden discontinuation of phenytoin and wants to restart it under your guidance. As a treating neurologist, while prescribing phenytoin, all of the following advices can be given except",
      "unique_key": "Q9800651",
      "question_audio": null,
      "question_video": null,
      "map_id": 34307382,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) He should continue the rest of the drugs as a part of his DVT treatment. Explanation for the Correct Answer: Phenytoin interacts significantly with warfarin and aspirin, making it necessary to monitor and possibly adjust anticoagulant therapy rather than continuing the same regimen unchanged. Phenytoin induces CYP2C9 and CYP3A4, which can increase warfarin metabolism, leading to reduced anticoagulant effect and increasing the risk of DVT recurrence. However, at higher doses, phenytoin displaces warfarin from plasma proteins, potentially increasing INR and leading to bleeding risk. Aspirin can enhance the bleeding risk due to its antiplatelet effect, especially when combined with warfarin. Regular INR monitoring and dose adjustments are required when restarting phenytoin in patients on warfarin therapy. Explanation for the Incorrect Answers: A) Patient should not take drug dose more than 400 mg/day Correct advice because phenytoin exhibits nonlinear pharmacokinetics (zero-order kinetics) at higher doses. Doses above 400 mg/day can lead to toxic accumulation due to enzyme saturation, increasing the risk of nystagmus, ataxia, and CNS toxicity. B) He should not frequently switch to other generic phenytoin preparations available in the market to make treatment more economical Correct advice because different phenytoin formulations may have variations in bioavailability, potentially leading to subtherapeutic or toxic effects. Even small changes in serum phenytoin levels can lead to breakthrough seizures or toxicity due to its narrow therapeutic index. D) Cholecalciferol supplementation to be taken on & off during treatment Correct advice because long-term phenytoin use induces CYP enzymes, increasing vitamin D metabolism and leading to osteomalacia and osteoporosis. Regular vitamin D and calcium supplementation is recommended to prevent bone demineralization.",
      "correct_choice_id": 266851,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6191681700305663/6191681700305663.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6191681700305663/6191681700305663.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74041,
      "choices": [
        {
          "id": 266853,
          "text": "Sodium valproate"
        },
        {
          "id": 266854,
          "text": "Phenobarbitone"
        },
        {
          "id": 266855,
          "text": "Levitiracetam"
        },
        {
          "id": 266856,
          "text": "Fosphenytoin"
        }
      ],
      "text": "An obese patient comes to you in hospital emergency with status epilepticus and he is stablised by a duty doctor with IV lorazepam 0.4 mg stat and immediately started with IV infusion of broad spectrum antiepileptic . All of the following drugs can be given as IV bolus in above patient except",
      "unique_key": "Q5792135",
      "question_audio": null,
      "question_video": null,
      "map_id": 34199321,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Phenobarbitone. Explanation for the Correct Answer: Phenobarbitone (phenobarbital) is not preferred as an IV bolus in status epilepticus due to its slow onset of action and significant risk of respiratory depression. Although phenobarbitone is an effective broad-spectrum antiepileptic, it takes 15–20 minutes to reach peak CNS concentration after IV administration, which is too slow for immediate seizure control. It causes profound CNS depression, including respiratory depression and hypotension, especially in obese patients or those with comorbidities. It is usually reserved for refractory status epilepticus or when other first-line agents fail. Explanation for the Incorrect Answers: A) Sodium valproate Can be given as IV bolus in status epilepticus. It has a rapid onset and is effective for generalized and focal seizures. Does not cause significant respiratory depression, making it a safer choice in critically ill patients. C) Levetiracetam Can be given as IV bolus and is well-tolerated with minimal side effects. No significant cardiac or respiratory depression, making it ideal for emergency use. Dosing is simple and does not require serum level monitoring. D) Fosphenytoin Prodrug of phenytoin, rapidly converted to active drug in the body. Can be given as IV bolus because it has better solubility and fewer side effects compared to phenytoin. Preferred over phenytoin due to lower risk of infusion-site reactions and cardiotoxicity.",
      "correct_choice_id": 266854,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56255001700305678/56255001700305678.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56255001700305678/56255001700305678.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74042,
      "choices": [
        {
          "id": 266857,
          "text": "Alprazolam"
        },
        {
          "id": 266858,
          "text": "Lorazepam"
        },
        {
          "id": 266859,
          "text": "Temazepam"
        },
        {
          "id": 266860,
          "text": "Triazolam"
        }
      ],
      "text": "A 47-year-old man with a history of intermittent panic disorders presents to his primary care physician desiring therapy. He has no other pertinent past medical or surgical history. Physical examination of the heart, lungs, and abdomen are within normal limits. What is the most appropriate treatment for this patient?",
      "unique_key": "Q5621838",
      "question_audio": null,
      "question_video": null,
      "map_id": 34996897,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Alprazolam Alprazolam is a benzodiazepine commonly used in the treatment of panic disorder due to its rapid onset of action and efficacy in reducing anxiety. As this patient has a history of intermittent panic disorders, alprazolam is the most appropriate option for immediate relief of symptoms. It works by enhancing the effects of GABA, a neurotransmitter that inhibits neuronal excitability, thereby providing an anxiolytic effect. Alprazolam is especially helpful in short-term management or as a rescue medication for acute panic attacks, which fits the clinical presentation of this patient. Incorrect Options: B. Lorazepam Lorazepam is another benzodiazepine that is effective for anxiety and panic disorders. However, it has a slower onset of action compared to alprazolam, which may not provide the immediate relief necessary for panic attacks. While it can be used for panic disorders, it is typically not the first choice when rapid onset is desired. Additionally, lorazepam has a longer half-life, which may lead to prolonged sedation and a higher risk of dependency with long-term use. C. Temazepam Temazepam is primarily used as a sleep aid for insomnia and is not typically indicated for panic disorder or anxiety. Although it is a benzodiazepine, its sedative effects make it more suitable for managing sleep disturbances rather than acute or chronic anxiety or panic attacks. Therefore, it is not an appropriate choice for the treatment of panic disorder in this patient. D. Triazolam Triazolam is also a benzodiazepine, but it is primarily used for the short-term treatment of insomnia due to its very short half-life. While it may help induce sleep, triazolam does not provide long-lasting anxiolytic effects and is not appropriate for the treatment of panic disorders. Its short duration of action may also cause rebound anxiety and lead to increased frequency of use, which can result in dependency. Thus, it is not suitable for managing panic disorder in this patient.",
      "correct_choice_id": 266857,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/20752221700305176/20752221700305176.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/20752221700305176/20752221700305176.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74043,
      "choices": [
        {
          "id": 266861,
          "text": "Cocaine"
        },
        {
          "id": 266862,
          "text": "Fluoxetine"
        },
        {
          "id": 266863,
          "text": "Hydroxyzine"
        },
        {
          "id": 266864,
          "text": "Lorazepam"
        }
      ],
      "text": "A 20-year-old college student is brought to the emergency department by the hostel warden after being found by his roommate to have snorted cocaine several times in the past few days, the last time being 10 h previously. He was given a drug that sedated him, and he fell asleep. The drug that was used to counter this patient’s apparent cocaine withdrawal was very likely which of the following?",
      "unique_key": "Q5899068",
      "question_audio": null,
      "question_video": null,
      "map_id": 34029228,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Lorazepam. This patient is experiencing cocaine withdrawal, which can present with symptoms like fatigue, hypersomnia, increased appetite, depression, irritability, and anxiety. Unlike opioid withdrawal, cocaine withdrawal is not life-threatening, but it can lead to severe depression and agitation, increasing the risk of suicidal thoughts. Benzodiazepines, such as lorazepam, are commonly used to manage agitation, anxiety, and insomnia associated with stimulant withdrawal. They provide sedation, anxiolysis, and muscle relaxation by enhancing GABAergic activity in the central nervous system. This helps calm the patient, allowing them to rest and recover. Explanation of Incorrect Options: (A) Cocaine: Using cocaine to treat cocaine withdrawal is not appropriate. Cocaine is a dopamine reuptake inhibitor that causes euphoria, tachycardia, and hypertension. Re-administering cocaine would worsen addiction and dependence, rather than helping the patient recover from withdrawal. Symptomatic treatment with supportive care and sedatives (like benzodiazepines) is the preferred approach. (B) Fluoxetine: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used for depression, anxiety, and OCD. While depression is common in cocaine withdrawal, SSRIs are not used acutely because they take weeks to show full effect. Instead, benzodiazepines are preferred for immediate symptom relief. If the patient develops persistent depressive symptoms, an SSRI like fluoxetine may be considered later. (C) Hydroxyzine: Hydroxyzine is an antihistamine with sedative and anxiolytic properties, sometimes used for mild anxiety or insomnia. However, it is less effective than benzodiazepines in treating the agitation and anxiety of stimulant withdrawal. Benzodiazepines provide stronger sedation and muscle relaxation, making them the preferred choice.",
      "correct_choice_id": 266864,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46571441700305374/46571441700305374.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46571441700305374/46571441700305374.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74044,
      "choices": [
        {
          "id": 266865,
          "text": "Weight gain"
        },
        {
          "id": 266866,
          "text": "Alopecia"
        },
        {
          "id": 266867,
          "text": "Liver damage"
        },
        {
          "id": 266868,
          "text": "Osteomalacia"
        }
      ],
      "text": "Valproate causes all except",
      "unique_key": "Q8361336",
      "question_audio": null,
      "question_video": null,
      "map_id": 34396995,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Osteomalacia, as valproate does not typically cause osteomalacia. Osteomalacia is characterized by defective bone mineralization due to vitamin D deficiency, calcium or phosphate imbalance, and is more commonly associated with long-term use of enzyme-inducing antiepileptic drugs such as phenytoin, carbamazepine, and phenobarbital. Unlike these drugs, valproate is not an enzyme inducer and does not significantly affect vitamin D metabolism to the extent that it leads to osteomalacia. However, prolonged use of valproate may contribute to bone mineral density reduction, but it is not a primary cause of osteomalacia. Explanation of Incorrect Options: Option A - Weight gain: Correct. Valproate commonly causes weight gain, which is attributed to increased appetite and metabolic changes. This effect is dose-dependent and occurs in a significant proportion of patients, particularly those taking valproate for epilepsy or bipolar disorder. Option B - Alopecia: Correct. Hair loss (alopecia) is a known side effect of valproate, typically presenting as diffuse thinning or hair texture changes. The exact mechanism is unclear but may be related to valproate-induced alterations in zinc and selenium metabolism. This effect is often reversible upon discontinuation or dose reduction. Option C - Liver damage: Correct. Hepatotoxicity is a serious but rare side effect of valproate, particularly in young children under two years of age or those with underlying metabolic disorders. Valproate-induced liver damage is thought to be due to mitochondrial toxicity and impaired fatty acid metabolism, leading to elevated liver enzymes and, in severe cases, fatal hepatic failure. Regular liver function tests (LFTs) are recommended for patients on long-term valproate therapy.",
      "correct_choice_id": 266868,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/5313871727679975/5313871727679975.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/5313871727679975/5313871727679975.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74045,
      "choices": [
        {
          "id": 266869,
          "text": "Drug interaction"
        },
        {
          "id": 266870,
          "text": "Topiramate side effects"
        },
        {
          "id": 266871,
          "text": "Hypoglycemia"
        },
        {
          "id": 266872,
          "text": "Dehydration"
        }
      ],
      "text": "A 40-year-old woman with a long history of migraines is started on topiramate as a preventive measure. After a month of treatment, she reports a significant decrease in headache frequency but also mentions new-onset tingling in her fingers and difficulty concentrating. What is the most likely cause of her symptoms?",
      "unique_key": "Q5685418",
      "question_audio": null,
      "question_video": null,
      "map_id": 34320586,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Topiramate side effects. Topiramate is an anticonvulsant that is also used for migraine prophylaxis. It works by blocking voltage-gated sodium channels, enhancing GABA activity, and inhibiting carbonic anhydrase. These mechanisms contribute to its neurological and metabolic side effects. Paresthesia (tingling in fingers and toes) is one of the most common side effects, likely due to carbonic anhydrase inhibition leading to metabolic acidosis. Additionally, cognitive difficulties such as trouble concentrating, memory issues, and word-finding difficulties—often referred to as “dopamax” effect—are also well-known side effects. These effects are typically dose-dependent and may improve by reducing the dose or ensuring adequate hydration. Explanation of Incorrect Options: Option A - Drug interaction: Incorrect. While topiramate can interact with some drugs (e.g., decreasing the effectiveness of oral contraceptives at high doses), there is no evidence in this case suggesting a significant interaction leading to paresthesia or cognitive dysfunction. These symptoms are more directly linked to topiramate’s inherent pharmacologic effects rather than drug interactions. Option C - Hypoglycemia: Incorrect. Hypoglycemia can cause neurological symptoms such as confusion, dizziness, and sweating, but paresthesia is not a primary symptom. Additionally, the patient’s symptoms are persistent rather than episodic, making hypoglycemia less likely. Option D - Dehydration: Incorrect. While topiramate can increase the risk of dehydration due to its carbonic anhydrase inhibition and potential for kidney stone formation, dehydration would more likely cause dry mouth, dizziness, and fatigue rather than the tingling sensation (paresthesia) and cognitive issues described.",
      "correct_choice_id": 266870,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16658051727680008/16658051727680008.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16658051727680008/16658051727680008.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74046,
      "choices": [
        {
          "id": 266873,
          "text": "Increase the escitalopram dosage"
        },
        {
          "id": 266874,
          "text": "Add a benzodiazepine for sleep"
        },
        {
          "id": 266875,
          "text": "Switch to a different class of antidepressants"
        },
        {
          "id": 266876,
          "text": "Add bupropion to the regimen"
        }
      ],
      "text": "A 55-year-old male with a history of depression is started on escitalopram. After two months, he reports a return of depressive symptoms and difficulty sleeping. The physician considers changing his treatment plan. Which of the following would be the most appropriate next step?",
      "unique_key": "Q5298462",
      "question_audio": null,
      "question_video": null,
      "map_id": 34807450,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Add bupropion to the regimen. Bupropion is an atypical antidepressant that acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). It is often used as an adjunct to selective serotonin reuptake inhibitors (SSRIs) like escitalopram in cases of partial response or residual symptoms. Since bupropion does not cause sedation and is associated with improved energy and motivation, it is particularly useful in patients experiencing residual depressive symptoms and difficulty sleeping due to SSRI-induced apathy or fatigue. Additionally, bupropion does not cause weight gain or sexual dysfunction, making it a favorable choice for augmentation. Explanation of Incorrect Options: Option A - Increase the escitalopram dosage: Incorrect. While increasing the dose of an SSRI can sometimes be beneficial, escitalopram has a dose-dependent risk of QT prolongation. If a patient has already been on an optimal dose for two months with only partial improvement, augmentation with another agent is preferred over a dose increase. Option B - Add a benzodiazepine for sleep: Incorrect. While benzodiazepines like lorazepam or clonazepam can help with sleep disturbances, they are not ideal for long-term treatment due to risks of dependence, tolerance, and withdrawal. Additionally, benzodiazepines do not address the underlying depression and may even worsen mood symptoms over time. Option C - Switch to a different class of antidepressants: Incorrect. Switching to another antidepressant class, such as serotonin-norepinephrine reuptake inhibitors (SNRIs) or tricyclic antidepressants (TCAs), may be considered if the patient had no response to escitalopram. However, since the patient has some improvement but still has residual symptoms, augmentation with bupropion is a more appropriate first-line strategy rather than switching to an entirely new drug class.",
      "correct_choice_id": 266876,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10939601727680025/10939601727680025.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10939601727680025/10939601727680025.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}